glp 1 and pancreas Cardiovascular, brain effects of GLP-1 The Role of GLP-1 Signaling
Description
Changes in Glucose-Lowering Drug Use before and after Cancer Diagnosis in Patients with Diabetes
Document GI effects, abdominal pain, and signs of pancreatitis or gallbladder disease, and assess hypoglycemia risk if insulin or a sulfonylurea is on board
Existing extended-release options, like weekly formulations of semaglutide and dulaglutide, have reduced injection frequency, and future innovations may include monthly formulations or implantable devices that deliver continuous therapy
Buford, by enhancing the effects of GLP1, these medications help to reduce hunger and increase feelings of fullness, leading to reduced caloric intake without the need for extreme dieting or willpower
